Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'
- Kreuzberger, Nina
- Hirsch, Caroline
- Chai, Khai Li
- Tomlinson, Eve
- Khosravi, Zahra
- Popp, Maria
- Neidhardt, Miriam
- Salomon, Susanne
- Piechotta, Vanessa
- Valk, Sarah J
- Monsef, Ina
- Wood, Erica M
- So-Osman, Cynthia
- Roberts, David J
- McQuilten, Zoe
- Estcourt, Lise J
- Skoetz, Nicole
Publication date
May 2021
DOIAbstract
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.funded by the Federal Ministry of Education and Research, Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project "COVIM"
Add to ORKG